DrugPatentWatch Prior Art Section
Other Dashboards:
Small Molecule Drugs
Biologics
Excipients
Drug Price
Drug Sales
Litigation
Investigational Drugs
Patent and Publication Search
Patents | Case name | Date Filed |
8,377,474, 8,454,998, 8,557,283, 9,089,607, 9,089,608, 9,463,246, 9,533,046, 9,901,640 | IMPAX LABORATORIES, LLC v. ASCENT PHARMACEUTICALS INC. | 2024-04-18 |
9,731,082 | Fresenius Kabi USA, LLC v. Natco Pharma USA LLC | 2024-04-12 |
10,300,065 | AstraZeneca AB v. Laurus Labs Limited | 2024-04-11 |
10,117,836 | ABBVIE INC. v. MSN PHARMACEUTICALS INC. | 2024-04-08 |
8,163,904, 8,293,756, 8,389,537, 8,415,363, 8,501,760, 9,061,029 | Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals Inc. | 2024-04-04 |
10,117,836 | ABBVIE INC. v. AUROBINDO PHARMA U.S.A., INC. | 2024-03-29 |
8,198,262, 8,828,427, 9,993,467, 10,555,939 | New York Hotel Trades Council & Hotel Association of New York City, Inc., Health Center Inc. v. Celgene Corporation | 2024-03-25 |
9,539,218 | Bayer Intellectual Property GmbH v. Prinston Pharmaceutical, Inc. | 2024-03-14 |
7,284,474, 7,396,341, 7,837,235, 7,896,264, 8,022,082, 8,733,341, 9,027,967 | Massachusetts Laborers' Health & Welfare Fund v. Boehringer Ingelheim Pharmaceuticals, Inc. | 2024-03-06 |
7,587,988, 8,132,712, 8,534,281, 8,931,476, 8,978,966, 9,463,289, 9,808,587, 10,561,808 | TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. v. CIPLA USA, INC. | 2024-02-16 |
Patent | Petitioner | Filing Date | Trial Type |
10,335,462 | Apotex Inc. et al. | 2024-03-01 | IPR |
10,335,462 | Sun Pharmaceutical Industries Ltd. et al. | 2023-11-02 | IPR |
10,335,462 | DR. REDDY'S LABORATORIES, INC. et al. | 2023-10-20 | IPR |
9,718,880 | Samsung Bioepis Co., Ltd. | 2023-05-31 | IPR |
9,732,149 | Samsung Bioepis Co., Ltd. | 2023-05-18 | IPR |
8,536,122 | Mylan Pharmaceuticals Inc. et al. | 2023-03-16 | IPR |
8,129,343 | Mylan Pharmaceuticals Inc. et al. | 2023-03-16 | IPR |
10,335,462 | Mylan Pharmaceuticals Inc. et al. | 2023-03-16 | IPR |
10,272,083 | Sandoz Inc. | 2023-02-03 | IPR |
8,377,903 | Hopewell Pharma Ventures, Inc. et al. | 2023-01-23 | IPR |